Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro

Organic-metal complexes are promising molecules for use in photodynamic therapy (PDT). The aim of this study was to investigate in vitro effects of novel Ru(ii) and Ir(iii) BODIPY complexes for PDT. These hybrid organic-metal molecules (Ru-BD and Ir-BD) have been synthesized via reactions of a BODIPY precursor (BD) with a phenanthroline unit bearing Ru(ii) (3) and novel Ir(iii) (4) compounds. The crystal structures of the new distyryl BODIPY (BD) and Ru(ii) complex (3) are also reported. The photophysical and singlet oxygen generation properties of Ru-BD and Ir-BD were investigated in comparison with unsubstituted BODIPY (BD). Moreover, Ru-BD and Ir-BD have been biologically evaluated in vitro in chronic myeloid leukemia and cervical cancer cell lines in terms of photodynamic therapy efficacy in the presence of BD control. These complexes were not toxic in the dark but red light was needed to induce cell death. These data support the fact that Ru-BD could be accepted as a valuable photosensitizer-drug for further PDT treatment.

Selective Cu-Catalyzed Intramolecular Annulation of 3-Aryl/Heteryl-2-(diazoacetyl)-1H-pyrroles: Synthesis of Benzo/Furo/Thieno[e]-Fused 1H-Indol-7-oles and Their Transformations

The Co(III)-catalyzed reaction of 1,3-dicarbonyl compounds with 2-(diazoacetyl)-2H-azirines, prepared by a simplified procedure from 2H-azirin-2-carbonyl chlorides, led in high yields to the formation of 2-(diazoacetyl)pyrroles, while leaving the diazoacetyl function intact. The intramolecular aromatic substitution reaction of 2-(diazoacetyl)pyrroles, catalyzed by Cu(OTf)₂, provided selectively previously unknown benzo[e]- and hetero[e]-fused indol-7-oles in good yields. Formylation of benzo[e]indol-4-ol led selectively to the 5-formyl derivative, which is a good precursor for an unusual salen ligand and its Ni-complex. Triflates prepared from benzo[e]indol-4-oles gave various 4-substituted benzo[e]indoles carrying aryl, 2-thienyl, 2-pyridyl, and alkynyl groups, in excellent yields using cross-coupling reactions. 4-(2-Pyridyl)benzo[e]indoles, upon treatment with BF₃·Et₂O/Et₃N, afforded a new type of fluorescent boron complexes with large Stokes shifts.

Methylated Unsymmetric BODIPY Compounds: Synthesis, High Fluorescence Quantum Yield and Long Fluorescence Time

We show that unsymmetric BODIPY compounds with one, two, and three methyl groups can be synthesized easily and efficiently by the unsymmetric reaction method. Their steady state and time-resolved fluorescence properties are examined in solvents of different polarity. These compounds show high fluorescence quantum yields (0.87 to 1.0), long fluorescence lifetimes (5.89 to 7.40 ns), and small Stokes shift (199 to 443 cm^-1). The methyl substitution exhibits influence on the UV-Vis absorption and fluorescence properties, such as the blue shift in emission and absorption spectra. It is the number rather than the position of methyls that play major roles. Except for 3 M-BDP, the increase in the number of methyls on BODIPY core leads to the increase in both fluorescence quantum yield and radiative rate constant, but causes the decrease in fluorescence lifetime. H-bonding solvents increase both the fluorescence lifetime and quantum yields. The methylated BODIPYs show the ability to generate singlet oxygen (¹Δ_g) which is evidenced by near-IR luminescence and DPBF chemical trapping techniques. The formation quantum yield of singlet oxygen (¹Δ_g) for the compounds is up to 0.15 ± 0.05.

A maltoheptaose-decorated BODIPY photosensitizer for photodynamic inactivation of Gram-positive bacteria

A maltoheptaose-decorated BODIPY with high singlet oxygen generation efficacy was synthesized for photodynamic inactivation of Gram-positive bacteria in planktonic forms and biofilms.

Synthesis of a triphenylamine BODIPY photosensitizer with D–A configuration and its application in intracellular simulated photodynamic therapy

A D–A type triphenylamine BODIPY fluorescent dye with AIE characteristics makes progress in photodynamic therapy.

De Novo Design of Phototheranostic Sensitizers Based on Structure-Inherent Targeting for Enhanced Cancer Ablation

Structure-inherent targeting (SIT) agents are of particular importance for clinical precision medicine; however, there still exists a great lack of SIT phototheranostics for simultaneous cancer diagnosis and targeted photodynamic therapy (PDT). Herein, for the first time, we propose a "one-for-all" strategy by using the Förster resonance energy transfer (FRET) mechanism to construct such omnipotent SIT phototheranostics. Of note, this novel tactic can not only endow conventional sensitizers with highly effective native tumor-targeting potency but also simultaneously improve their photosensitization activities, resulting in dramatically boosted therapeutic index. After intravenous injection of the prepared SIT theranostic, the neoplastic sites are distinctly "lighted up" and distinguished from neighboring tissues, showing a near-infrared signal-to-background ratio value as high as 12.5. More importantly, benefiting from the FRET effect, markedly amplified light-harvesting ability and ¹O₂ production are demonstrated. Better still, other favorable features are also simultaneously achieved, including specific mitochondria anchoring, augmented cellular uptake (>13-fold), as well as ideal biocompatibility, all of which allow orders-of-magnitude promotion in anticancer efficiency both in vitro and in vivo. We believe this one-for-all SIT platform will provide a new idea for future cancer precision therapy.